A.R.T. Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-7,077
Closed -$655K – 784
2019
Q4
$655K Buy
+7,077
New +$595K 0.03% 726
2019
Q1
– Sell
-30,977
Closed -$1.63M – 1555
2018
Q4
$1.63M Buy
+30,977
New +$1.82M 0.11% 282
2017
Q2
– Sell
-5,842
Closed -$205K – 1670
2017
Q1
$205K Buy
+5,842
New +$185K 0.01% 1162
2016
Q3
– Sell
-13,308
Closed -$364K – 1072
2016
Q2
$364K Buy
+13,308
New +$340K 0.02% 899
2015
Q4
– Sell
-10,551
Closed -$293K – 1671
2015
Q3
$293K Buy
+10,551
New +$381K 0.01% 1051
2014
Q2
– Sell
-26,077
Closed -$335K – 1490
2014
Q1
$335K Buy
26,077
+6,787
+35% +$97.3K 0.02% 945
2013
Q4
$263K Sell
19,290
-38,595
-67% -$461K 0.01% 1015
2013
Q3
$641K Sell
57,885
-48,016
-45% -$478K 0.04% 667
2013
Q2
$872K Buy
+105,901
New +$889K 0.03% 681

Other funds holding RGEN

A.R.T. Advisors's RGEN Position: Q1 2020 in Review

A.R.T. Advisors sold out of Repligen (RGEN) in Q1 2020, closing a stake of 7,077 shares — an estimated $655K sold.

A.R.T. Advisors first reported a position in RGEN in Q2 2013 and held it in 9 quarters. The position peaked at $1.63M in Q4 2018. 309 funds tracked by Wall St. Rank hold RGEN as of Q1 2020.

  • A.R.T. Advisors reported no remaining Repligen position as of Q1 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 7,077 Repligen shares in Q1 2020, an estimated $655K.
  • A.R.T. Advisors first reported a position in Repligen in Q2 2013 and held it in 9 quarters.
  • A.R.T. Advisors's Repligen position peaked at $1.63M in Q4 2018.
  • 309 funds tracked by Wall St. Rank held Repligen as of Q1 2020.

Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.